Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren for Atrial Fibrillation in Pacemaker Patients
NCT02909166Phase 3Unknown
- Start
- Jan 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in Atrial fibrillation (AFib). Status: unknown.
02
Drugs
aliskiren
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02909166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909166.